The Enterprise Value as of November 2024 (TTM) for Interpace Biosciences, Inc. (IDXG) is 10.79M

According to Interpace Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.79M. This represents a change of -2.33% compared to the average of 11.05M of the last 4 quarters.

Interpace Biosciences, Inc. (IDXG) Historical Enterprise Value (quarterly & annually)

How has IDXG Enterprise Value performed in the past?

The mean historical Enterprise Value of Interpace Biosciences, Inc. over the last ten years is 17.80M. The current 10.79M Enterprise Value has changed 5.96% with respect to the historical average. Over the past ten years (40 quarters), IDXG's Enterprise Value was at its highest in in the June 2021 quarter at 50.26M. The Enterprise Value was at its lowest in in the June 2017 quarter at -5694952.14.

Interpace Biosciences, Inc. (IDXG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Interpace Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Interpace Biosciences, Inc. (IDXG) Average Enterprise Value

How has IDXG Enterprise Value performed in the past?

The current Enterprise Value of Interpace Biosciences, Inc. (IDXG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Interpace Biosciences, Inc. (IDXG) Enterprise Value vs. Peers

How is IDXG’s Enterprise Value compared to its peers?

Interpace Biosciences, Inc.’s Enterprise Value is greater than Intelligent Bio Solutions Inc. (3.62M), less than bioAffinity Technologies, Inc. (19.84M), less than SeqLL Inc. (81.77M), greater than Biocept, Inc. (-788000.00), less than FONAR Corporation (90.09M), greater than Burning Rock Biotech Limited (-29410816.44), less than Sera Prognostics, Inc. (212.96M), less than Olink Holding AB (publ) (3.16B), less than LumiraDx Limited (301.24M), greater than HTG Molecular Diagnostics, Inc. (-6314079.00), less than bioAffinity Technologies, Inc. (19.84M), greater than Genetron Holdings Limited (0), less than Exagen Inc. (73.55M), less than OncoCyte Corporation (46.25M), less than Personalis, Inc. (204.95M), greater than iSpecimen Inc. (3.71M), less than Trinity Biotech plc (107.59M),

Build a custom stock screener for Interpace Biosciences, Inc. (IDXG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Interpace Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Interpace Biosciences, Inc. (IDXG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Interpace Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.